Papers
8
Total Citations
68
H-Index
5
About
Matteo Rottoli is a leading colorectal surgeon at a tertiary referral center, pioneering the clinical integration of next-generation robotic platforms. His primary research focuses on the safety, feasibility, and oncologic outcomes of robotic-assisted surgery for colorectal cancer and inflammatory bowel disease (IBD), with a specific emphasis on the novel Medtronic Hugo™ RAS system. Rottoli’s major contributions include developing and validating a multi-docking strategy for robotic low anterior resection (LAR) and deep pelvic surgery, as well as authoring the first worldwide comparative study demonstrating that the Hugo™ RAS system achieves perioperative and oncologic outcomes comparable to standard laparoscopy for colorectal cancer. His work on the first 17 consecutive alimentary tract surgeries with this platform established its initial safety profile, earning 17 citations. Beyond platform validation, he has investigated the standardization of lymphadenectomy in laparoscopic right hemicolectomy through the SICE network and explored the application of augmented reality in robotic general surgery. With over 60 combined citations across his most-cited works, Rottoli is a key voice in the transition toward modular, multi-quadrant robotic surgery, providing essential evidence for the adoption of new technologies in colorectal practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8